PureTech Health has announced a collaboration with Boehringer Ingelheim to advance immuno-oncology product candidates, using its lymphatic targeting platform.
of Atul Pande, M.D., as the Company’s Chief Medical Officer. In this new role, Dr. Pande will oversee all clinical operations across PureTech Health’s pipeline and work closely with the team to de-risk and advance opportunities that hold the most po